Abiopharma

News list

Grant Grady III 🟡 adjusted position in 0 shares (1 derivative) of Aptevo Therapeutics Inc. (APVO) Transaction Date: Aug 06, 2026 | Filing ID: 343072

Full text

News bot Aug. 11, 2026, 1:36 a.m.
🔍 Grant Grady III (Executive)

Company: Aptevo Therapeutics Inc. (APVO)

Report Date: 2026-08-06
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 400
- Total shares sold: 400
Detailed Transactions and Holdings:
- Acquired 400 shares of Common Stock (Direct)
  Date: 2026-08-06 | Code: M | equity_swap_involved: false | shares_owned_after: 1,150.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 400 shares of Restricted Stock Unit (Derivative)
  Date: 2026-08-06 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- F2: On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant.